Below are the financial statements of Biogen, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 as of 2024-12-31 | 2023 as of 2023-12-31 |
|---|---|---|
| Assets | — | — |
| Current assets | — | — |
| Cash and cash equivalents | 2,375a | 1,049.9a |
| Accounts receivable, net | 1,404.8a | 1,664.1a |
| Due from anti-CD20 therapeutic programs | 464a | 435.9a |
| Inventory | 2,460.5a | 2,527.4a |
| Other current assets | 752.5a | 1,182a |
| Total current assets | 7,456.8a | 6,859.3a |
| Property, plant and equipment, net | 3,181.3a | 3,309.7a |
| Operating lease assets | 356.4a | 420a |
| Intangible assets, net | 9,691.2a | 8,363a |
| Goodwill | 6,478.9a | 6,219.2a |
| Deferred tax asset | 324.2a | 928.6a |
| Investments and other assets | 560.5a | 745a |
| Total assets | 28,049.3a | 26,844.8a |
| Liabilities and equity | — | — |
| Current liabilities | — | — |
| Current portion of notes payable and term loan | 1,748.6a | 150a |
| Taxes payable | 548.3a | 257.4a |
| Accounts payable | 424.2a | 403.3a |
| Accrued expense and other | 2,807.7a | 2,623.6a |
| Total current liabilities | 5,528.8a | 3,434.3a |
| Notes payable and term loan | 4,547.2a | 6,788.2a |
| Deferred tax liability | 190.5a | 641.8a |
| Long-term operating lease liabilities | 334.5a | 400a |
| Other long-term liabilities | 732.3a | 781.1a |
| Total liabilities | 11,333.3a | 12,045.4a |
| Equity: Biogen Inc. shareholders’ equity | — | — |
| Preferred stock | 0a | 0a |
| Common stock | 0.1a | 0.1a |
| Additional paid-in capital | 569.4a | 302.5a |
| Accumulated other comprehensive income (loss) | -136.2a | -153.7a |
| Retained earnings | 19,259.8a | 17,627.6a |
| Treasury stock, at cost | -2,977.1a | -2,977.1a |
| Total equity | 16,716a | 14,799.4a |
| Total liabilities and equity | 28,049.3a | 26,844.8a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.